March 29, 2017

Athersys to Present at Needham Healthcare Conference on April 4

CLEVELAND, March 29, 2017 (GLOBE NEWSWIRE) -- Athersys, Inc. (NASDAQ:ATHX) announced today that Gil Van Bokkelen, Chairman and CEO, will present a corporate overview at the 16th Annual Needham Healthcare Conference at The Westin New York Grand Central Hotel in New York City.  The presentation is scheduled for Tuesday, April 4, 2017 at 12:10 pm ET.

Investors interested in arranging a meeting with the Company's management during this conference should contact the conference coordinator.

A live webcast of the presentation can be accessed by visiting ‘Events & Presentations' in the Investors Section on the Company's website at An archived replay of the webcast will be available for 90 days on the Company's website after the conference.

About Athersys

Athersys is an international biotechnology company engaged in the development of therapeutic products designed to extend and enhance the quality of human life. The Company is developing its MultiStem ® cell therapy product, a patented, adult-derived "off-the-shelf" stem cell product, initially for disease indications in the neurological, cardiovascular, and inflammatory and immune disease areas, and has several ongoing clinical trials evaluating this potential regenerative medicine product. Athersys has forged strategic partnerships and a broad network of collaborations to further advance MultiStem cell therapy toward commercialization. More information is available at Follow Athersys on Twitter at



William (B.J.) Lehmann, J.D.

President and Chief Operating Officer

Tel: (216) 431-9900

David Schull

Russo Partners, LLC

Tel: (212) 845-4271 or (858) 717-2310

Investor Contact:

Peter Vozzo

Westwicke Partners

(443) 213-0505 or (443) 377-4767 (mobile)

Primary Logo

Source: Athersys, Inc.

News Provided by Acquire Media

Close window | Back to top

Copyright 2018 Athersys